SRIVASSO RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

tiotropium bromide monohydrate, Quantity: 3.1235 microgram/actuation (Equivalent: tiotropium, Qty 2.5 microgram/actuation)

Disponibbli minn:

Boehringer Ingelheim Pty Ltd

INN (Isem Internazzjonali):

Tiotropium bromide monohydrate

Għamla farmaċewtika:

Inhalation, conventional

Kompożizzjoni:

Excipient Ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride

Rotta amministrattiva:

Inhalation

Unitajiet fil-pakkett:

60 actuations (1 cartridge) + Respimat inhaler (inhalation device)

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

COPD: SRIVASSO RESPIMAT is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (COPD). SRIVASSO RESPIMAT is indicated for the prevention of COPD exacerbations.,Asthma: SRIVASSO RESPIMAT is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.

Sommarju tal-prodott:

Visual Identification: Clear, colourless solution.; Container Type: Cartridge; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2016-06-08